Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > financials question

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Apr 27, 2023 11:29am

117 Views

Post# 35417069

RE:RE:RE:RE:RE:financials question

Hi PBMTORBUST, sales in their lazer division is currently towards the therapeutic market, I may be wrong here but once the NMIBC treatment gets the thumbs up from Health Canada and the US FDA their sales in the Lazer used in this treatment will be purchased by hospitals thus greatly increasing revenue. Everything is tied together.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant